Evidence map›Paper›PMID 42045479›Full record

ArticleNature metabolism2026

Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion.

Timothy Budden, Noah Palombo, Shilpa Gurung, Martha Gutteridge, Charlotte Russell, Jair Marques, Alex von Kriegsheim, Lyutong An, Catherine Harwood, Luisa Motta and 8 more

Abstract read
In one paragraph

Article in Nature metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Timothy BuddenSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. timothy.budden@liverpool.ac.uk.ORCID http://orcid.org/0000-0003-2500-2814
Noah PalomboSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.ORCID http://orcid.org/0009-0003-6370-2712
Shilpa GurungSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Martha GutteridgeSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.ORCID http://orcid.org/0009-0001-0458-5603
Charlotte RussellSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Jair MarquesCRUK Scotland Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.
Alex von KriegsheimCRUK Scotland Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-4952-8573
Lyutong AnSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.ORCID http://orcid.org/0009-0007-1581-7979
Catherine HarwoodCentre for Cell Biology and Cutaneous Research, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
Luisa MottaDepartment of Histopathology, Salford Royal Hospital, Northern Care Alliance, Manchester, UK.
Claus JorgensenSystems Oncology, Cancer Research UK Manchester Institute, Manchester, UK.
Carlos López-GarcîaNorth Wales Medical School, University of Bangor, Bangor, UK.
Caroline Gaudy-MarquesteAix-Marseille University, APHM, Hôpital Timone, Service de Dermatologie et de Cancérologie cutanée, Marseille, France.
Kevin HarringtonHead and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Malin PedersenHead and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0003-1887-733X
Ben O'LearyHead and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Antonio RullanTargeted Therapy Team, The Institute of Cancer Research, London, UK.ORCID http://orcid.org/0000-0002-7365-9629
Amaya VirósSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. amaya.viros@cruk.manchester.ac.uk.ORCID http://orcid.org/0000-0001-5177-5015

Funding

Cancer Research UK (CRUK) C5759/A31372Melanoma Research Alliance (MRA) #825648
6 · The paper itself

Abstract

Squamous cell carcinomas (SCCs) originate in epithelial tissues of older individuals who have been exposed to environmental carcinogens. Despite overlapping clinical hallmarks, SCCs from different anatomic sites have different prognoses. Here we show that fibroblasts confer site-specific cues that determine SCC proliferation and invasion. Oral and lung fibroblasts have distinct lipid metabolism, transferring unique lipids to SCC cells that promote epithelial-to-mesenchymal transition, and oral and lung SCC invasion. Whereas oral fibroblasts transfer sphingomyelins, which activate the ceramide-sphingosine-1-phosphate-STAT3 pathway and promote oral SCC invasion, lung fibroblasts transfer triglycerides to lung SCCs, thereby triggering cholesterol synthesis and invasion, which is associated with poor survival. By contrast, dermal fibroblasts are lipid poor, and cutaneous SCC is less invasive. Our data indicate that targeting fibroblast lipid synthesis and SCC lipid uptake or breakdown inhibits oral and lung epithelial cancer invasion.

Indexed as

Carcinoma, Squamous CellFibroblastsLipid MetabolismAnimalsCell Line, TumorCell ProliferationCeramidesEpithelial-Mesenchymal TransitionHumansLung NeoplasmsMouth NeoplasmsNeoplasm InvasivenessSphingosineCeramidesSphingosine

Identifiers

PMID42045479
PMCPMC13218938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.